These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32620797)

  • 41. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
    Wen X; Westergard T; Pasinelli P; Trotti D
    Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poly-GP in cerebrospinal fluid links
    Lehmer C; Oeckl P; Weishaupt JH; Volk AE; Diehl-Schmid J; Schroeter ML; Lauer M; Kornhuber J; Levin J; Fassbender K; Landwehrmeyer B; ; Schludi MH; Arzberger T; Kremmer E; Flatley A; Feederle R; Steinacker P; Weydt P; Ludolph AC; Edbauer D; Otto M
    EMBO Mol Med; 2017 Jul; 9(7):859-868. PubMed ID: 28408402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
    Starr A; Sattler R
    Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Dafinca R; Scaber J; Ababneh N; Lalic T; Weir G; Christian H; Vowles J; Douglas AG; Fletcher-Jones A; Browne C; Nakanishi M; Turner MR; Wade-Martins R; Cowley SA; Talbot K
    Stem Cells; 2016 Aug; 34(8):2063-78. PubMed ID: 27097283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of C9orf72-related dipeptides impairs motor function in a vertebrate model.
    Swaminathan A; Bouffard M; Liao M; Ryan S; Callister JB; Pickering-Brown SM; Armstrong GAB; Drapeau P
    Hum Mol Genet; 2018 May; 27(10):1754-1762. PubMed ID: 29528390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. von Economo Neuron Density and Thalamus Volumes in Behavioral Deficits in Frontotemporal Dementia Cases with and without a C9ORF72 Repeat Expansion.
    Yang Y; Halliday GM; Hodges JR; Tan RH
    J Alzheimers Dis; 2017; 58(3):701-709. PubMed ID: 28482638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Chemical Screen Identifies Compounds Limiting the Toxicity of C9ORF72 Dipeptide Repeats.
    Corman A; Jung B; Häggblad M; Bräutigam L; Lafarga V; Lidemalm L; Hühn D; Carreras-Puigvert J; Fernandez-Capetillo O
    Cell Chem Biol; 2019 Feb; 26(2):235-243.e5. PubMed ID: 30527999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 49. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
    Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
    Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy.
    Chew J; Cook C; Gendron TF; Jansen-West K; Del Rosso G; Daughrity LM; Castanedes-Casey M; Kurti A; Stankowski JN; Disney MD; Rothstein JD; Dickson DW; Fryer JD; Zhang YJ; Petrucelli L
    Mol Neurodegener; 2019 Feb; 14(1):9. PubMed ID: 30767771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders.
    Boivin M; Pfister V; Gaucherot A; Ruffenach F; Negroni L; Sellier C; Charlet-Berguerand N
    EMBO J; 2020 Feb; 39(4):e100574. PubMed ID: 31930538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An amyloid-like cascade hypothesis for C9orf72 ALS/FTD.
    Edbauer D; Haass C
    Curr Opin Neurobiol; 2016 Feb; 36():99-106. PubMed ID: 26555807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C9orf72 Gene Expression in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
    Shpilyukova YA; Fedotova EY; Abramycheva NY; Kochergin IA; Zakroyshchikova IV; Zakharova MN; Illarioshkin SN
    Bull Exp Biol Med; 2020 Sep; 169(5):673-676. PubMed ID: 32990847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identifying Cellular Nonsense-Mediated mRNA Decay (NMD) Targets: Immunoprecipitation of Phosphorylated UPF1 Followed by RNA Sequencing (p-UPF1 RIP-Seq).
    Kurosaki T; Hoque M; Maquat LE
    Methods Mol Biol; 2018; 1720():175-186. PubMed ID: 29236259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Global analyses of UPF1 binding and function reveal expanded scope of nonsense-mediated mRNA decay.
    Hurt JA; Robertson AD; Burge CB
    Genome Res; 2013 Oct; 23(10):1636-50. PubMed ID: 23766421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proline-arginine poly-dipeptide encoded by the C9orf72 repeat expansion inhibits adenosine deaminase acting on RNA.
    Suzuki H; Matsuoka M
    J Neurochem; 2021 Aug; 158(3):753-765. PubMed ID: 34081786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity.
    Kramer NJ; Haney MS; Morgens DW; Jovičić A; Couthouis J; Li A; Ousey J; Ma R; Bieri G; Tsui CK; Shi Y; Hertz NT; Tessier-Lavigne M; Ichida JK; Bassik MC; Gitler AD
    Nat Genet; 2018 Apr; 50(4):603-612. PubMed ID: 29507424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
    Tomiyama H
    Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD.
    Li S; Wu Z; Tantray I; Li Y; Chen S; Dong J; Glynn S; Vogel H; Snyder M; Lu B
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):25104-25115. PubMed ID: 32958650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.